drugset

drugset / Trial / NCT00700661

A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)

NCT00700661 ↗

Phase 3 Completed 500 enrolled Organon and Co

RandomizedParallel-groupDouble-blindTreatment

Summary

A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.

Timeline

Start: 2001-01
Primary completion: 2002-12
Completion: 2002-12

Publications

Background Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005 Feb 15;171(4):315-22. doi: 10.1164/rccm.200407-894OC. Epub 2004 Nov 12.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Montelukast	Other / unclassified	4 mg	—

Indications